COMPARISON OF THE MUTAGENICITY AND TERATOGENICITY OF CYCLOPHOSPHAMIDE AND ITS ACTIVE METABOLITES, 4-HYDROXYCYCLOPHOSPHAMIDE, PHOSPHORAMIDE MUSTARD, AND ACROLEIN

This publication has 21 references indexed in Scilit:

• Cyclophosphamide cystitis—Identification of acrolein as the causative agent
  Biochemical Pharmacology, 1979
• Teratogenic bioactivation of cyclophosphamide
  Life Sciences, 1979
• Carcinogenic action of low‐dose cyclophosphamide given orally to sprague‐dawley rats in a lifetime experiment
  International Journal of Cancer, 1979
• In vitro metabolism of cyclophosphamide in limb bud culture
  Teratology, 1979
• CONTROLLED CLINICAL STUDIES WITH AN ANTIDOTE AGAINST THE UROTOXICITY OF OXAZAPHOSPHORINES - PRELIMINARY-RESULTS
  1979
• CYCLOPHOSPHAMIDE-INDUCED ONCOGENIC TRANSFORMATION, CHROMOSOMAL BREAKAGE, AND SISTER CHROMATID EXCHANGE FOLLOWING MICROSOMAL ACTIVATION
  1978
• COMPARATIVE DISPOSITION OF PHOSPHORAMIDE MUSTARD AND OTHER CYCLOPHOSPHAMIDE METABOLITES IN MOUSE USING SALMONELLA-MUTAGENESIS ASSAY
  1978
• Mutagenic activity of major mammalian metabolites of cyclophosphamide toward several genes ofEscherichia coli
  Journal of Toxicology and Environmental Health, 1977
• Does nitrogen mustard affect the foetus directly or secondarily by its effect on the mother ?
  Cellular and Molecular Life Sciences, 1966
• STUDIES ON MECHANISM OF ACTION OF CYTOXAN EVIDENCE OF ACTIVATION IN VIVO AND IN VITRO
  1961